Recombinetics

Biotechnology ResearchMinnesota, United States11-50 Employees

Recombinetics is a biotechnology research company focused on gene repair and gene editing, developing and applying editing technologies to biomedical and agricultural contexts. Its work spans regenerative medicine, disease research, and animal agriculture, reflecting a broad scope of genome engineering applications. The firm operates from Minnesota in the United States, with its headquarters identified as located in St. Paul, Minnesota.

The company serves researchers and industry partners seeking genetic engineering capabilities to address complex biological challenges. It has pursued collaborations with academic and service organizations, including a 2020 joint effort with UT Southwestern Medical Center to investigate factors that improve the efficiency of generating interspecies chimera between pigs and humans, and a partnership with American Preclinical Services to study glioblastoma outcomes, illustrating its engagement in research collaborations. The organization is characterized as a smaller biotech firm within the broader field of biotechnology research.

Sign up for free to view info

Email Format Employee directory